$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Can you continue to take Anagrelide after taking it for 20 days and safety instructions
2026-02-01 22:25:32
Check Details
Is apalutamide (Ansenko) a targeted drug and an introduction to its treatment mechanism
2026-02-01 22:25:32
Check Details
Whether Elacetrant has been included in the medical insurance catalog and interpretation of relevant policies on medical insurance reimbursement
2026-02-01 22:25:32
Check Details
What is the therapeutic effect of F/TAF and a summary of clinical research and patient medication feedback?
2026-02-01 22:25:32
Check Details
Analysis of whether long-term use of Febuxostat (Febuxostat) is necessary once you start taking it
2026-02-01 22:25:32
Check Details
Analysis of the main functions, efficacy and clinical indications of furmonertinib
2026-02-01 22:25:32
Check Details
Analysis of whether long-term persistence is required after taking ensifentrine-Ohtuvayre and the risk of discontinuation
2026-02-01 22:25:32
Check Details
Discussion on whether Roaccutane (isotretinoin) is a hormonal drug and its long-term safety
2026-02-01 22:25:32
Check Details
Detailed instructions for standard usage, dosage and injection method of Doxorubicin
2026-02-01 22:25:32
Check Details
Common side effects of everolimus (Afinitor) and precautions for safe use
2026-02-01 22:25:32
Check Details
Summary of usage standards and medication precautions for estramustine (Adelox)
2026-02-01 22:25:32
Check Details
Changes in patients’ financial burden after Pralsetinib is covered by medical insurance
2026-02-01 22:25:32
Check Details
1
2
...
2138
2139
2140
2141
2142
2143
2144
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma